Merck may finally be entitled to a hefty insurance payout from the high-profile NotPetya cyberattack—if an appeals court ruling stands.
A New Jersey appellate court on Monday ruled that a group of insurers can’t use war as an argument to deny Merck coverage from the notorious cyberattack that afflicted the company and others back in 2017.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,